BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 10556673)

  • 21. Transducer abstraction: a novel approach to the detection of partial agonist efficacy in radioligand binding studies.
    Christopoulos A; Grant MK; El-Fakahany EE
    J Pharmacol Toxicol Methods; 2000; 43(1):55-67. PubMed ID: 11091130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of maximal activation of neuronal nitric oxide synthase at muscarinic M1 receptors following prolonged agonist treatment.
    Cuadra AE; El-Fakahany EE
    Eur J Pharmacol; 1997 Sep; 334(1):107-10. PubMed ID: 9346336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulating activity of M1 receptor to the reaction of ileal smooth muscle.
    Glaza I; Szadujkis-Szadurski L; Szadujkis-Szadurski R; Gajdus M; Olkowska J
    Postepy Hig Med Dosw (Online); 2011 Aug; 65():478-81. PubMed ID: 21918249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immediate and delayed consequences of xanomeline wash-resistant binding at the M3 muscarinic receptor.
    Noetzel MJ; Grant MK; El-Fakahany EE
    Neurochem Res; 2009 Jun; 34(6):1138-49. PubMed ID: 19082883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological characterization of muscarinic receptors in the uterus of oestrogen-primed and pregnant rats.
    Munns M; Pennefather JN
    Br J Pharmacol; 1998 Apr; 123(8):1639-44. PubMed ID: 9605571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pseudo-noncompetitive antagonism of muscarinic receptor-mediated cyclic GMP formation and phosphoinositide hydrolysis by pirenzepine.
    el-Fakahany EE; Surichamorn W; Amrhein CL; Stenstrom S; Cioffi CL; Richelson E; McKinney M
    J Pharmacol Exp Ther; 1988 Dec; 247(3):934-40. PubMed ID: 2849677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Muscarinic M1 receptor agonist actions of muscarinic receptor agonists in rabbit vas deferens.
    Shannon HE; Sawyer BD; Bemis KG; Bymaster FP; Health I; Mitch CH; Ward JS
    Eur J Pharmacol; 1993 Feb; 232(1):47-57. PubMed ID: 8458395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of cholinergic drugs on the concentration of intracellular free calcium of rat pituitary intermediate lobe cells.
    Némethy Z; Makara GB; Acs Z
    Brain Res Bull; 1999 Sep; 50(1):53-7. PubMed ID: 10507472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term changes in the muscarinic M1 receptor induced by instantaneous formation of wash-resistant xanomeline-receptor complex.
    De Lorme KC; Grant MK; Noetzel MJ; Polson SB; El-Fakahany EE
    J Pharmacol Exp Ther; 2007 Dec; 323(3):868-76. PubMed ID: 17855477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-affinity M(2) receptor binding state mediates mouse atrial bradycardia: comparative effects of carbamylcholine and the M(1) receptor agonists sabcomeline and xanomeline.
    Stengel PW; Cohen ML
    J Pharmacol Exp Ther; 2001 Mar; 296(3):818-24. PubMed ID: 11181912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative pharmacology of recombinant human M3 and M5 muscarinic receptors expressed in CHO-K1 cells.
    Watson N; Daniels DV; Ford AP; Eglen RM; Hegde SS
    Br J Pharmacol; 1999 May; 127(2):590-6. PubMed ID: 10385263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of cerebral function by CS-932, a functionally selective M1 partial agonist: neurochemical characterization and pharmacological studies.
    Iwata N; Kozuka M; Hara T; Kanek T; Tonohiro T; Sugimoto M; Niitsu Y; Kondo Y; Yamamoto T; Sakai J; Nagano M
    Jpn J Pharmacol; 2000 Nov; 84(3):266-80. PubMed ID: 11138727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muscarinic (M1) mediation of carbachol-induced theta in the cat entorhinal cortex in vitro.
    Gołebiewski H; Eckersdorf B; Błaszczyk M; Grabowski R; Konopacki J
    Neuroreport; 1994 Oct; 5(15):1989-92. PubMed ID: 7841392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective antagonism activity of alkaloids from bulbs Fritillariae at muscarinic receptors: functional studies.
    Lin BQ; Ji H; Li P; Jiang Y; Fang W
    Eur J Pharmacol; 2006 Dec; 551(1-3):125-30. PubMed ID: 17027747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term activation upon brief exposure to xanomleline is unique to M1 and M4 subtypes of muscarinic acetylcholine receptors.
    Šantrůčková E; Doležal V; El-Fakahany EE; Jakubík J
    PLoS One; 2014; 9(2):e88910. PubMed ID: 24558448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mixed agonist-antagonist properties of clozapine at different human cloned muscarinic receptor subtypes expressed in Chinese hamster ovary cells.
    Olianas MC; Maullu C; Onali P
    Neuropsychopharmacology; 1999 Mar; 20(3):263-70. PubMed ID: 10063486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The colon-selective spasmolytic otilonium bromide inhibits muscarinic M(3) receptor-coupled calcium signals in isolated human colonic crypts.
    Lindqvist S; Hernon J; Sharp P; Johns N; Addison S; Watson M; Tighe R; Greer S; Mackay J; Rhodes M; Lewis M; Stebbings W; Speakman C; Evangelista S; Johnson I; Williams M
    Br J Pharmacol; 2002 Dec; 137(7):1134-42. PubMed ID: 12429587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the M1 agonist xanomeline on processing of human beta-amyloid precursor protein (FAD, Swedish mutant) transfected into Chinese hamster ovary-m1 cells.
    DeLapp N; Wu S; Belagaje R; Johnstone E; Little S; Shannon H; Bymaster F; Calligaro D; Mitch C; Whitesitt C; Ward J; Sheardown M; Fink-Jensen A; Jeppesen L; Thomsen C; Sauerberg P
    Biochem Biophys Res Commun; 1998 Mar; 244(1):156-60. PubMed ID: 9514902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 6beta-acetoxy nortropane regulated processing of amyloid precursor protein in CHOm1 cells and rat brain.
    Qiu Y; Chen HZ; Wu XJ; Jin ZJ
    Eur J Pharmacol; 2003 May; 468(1):1-8. PubMed ID: 12729836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Muscarinic cholinergic receptors in brain and atrial membranes of adult brook trout (Salvelinus fontinalis) measured by radioligand binding techniques.
    Jones SB; King LB
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1995 Sep; 112(1):43-50. PubMed ID: 8564789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.